US Corporate Board Director Changes SEC Filings — April 01, 2026

01-04-2026

Consensus Cloud Solutions, Inc. promoted and appointed Adam Varon (61) as Chief Financial Officer and Karel Krulich (50) as Chief Accounting Officer, effective April 1, 2026. Varon's compensation includes an annual base salary of $345,000, eligibility for up to $150,000 annual bonus in 2026, a February 2026 equity grant valued at approximately $400,000 (8,818 performance-based RSUs and 8,818 time-based RSUs), and an additional equity grant of approximately $300,000 (12,637 time-based RSUs). Krulich's package comprises a $327,000 base salary, up to $100,000 bonus, a February 2026 equity grant worth approximately $375,000 (8,267 performance-based RSUs and 8,267 time-based RSUs), and an additional grant of approximately $275,000 (11,584 time-based RSUs).

• ·Equity grants vest over 3 years: 50% of performance-based RSUs based on 2026 financial metrics, remaining 50% based on stock price targets; time-based RSUs in 5 tranches.
• ·Appointments previously announced.
• ·Event and filing date: April 1, 2026.

01-04-2026

Zymeworks Inc. (Nasdaq: ZYME) announced the appointment of Kristin Stafford as Chief Financial Officer, effective April 1, 2026, to support strategic planning, capital allocation, and value creation. Stafford brings extensive experience from Royalty Pharma plc, BioPharma Credit plc, Ernst & Young LLP, and Deloitte. No financial metrics or performance changes were disclosed in the announcement.

• ·Stafford served as Senior Vice President, Chief Accounting Officer at Royalty Pharma since December 2018; previously Vice President, Finance at Royalty Pharma and CFO of BioPharma Credit plc (2016-2018).
• ·Stafford is a CPA, holds B.Sc. in business administration from Sonoma State University, and is currently a Board Member at Novocure.
• ·Filing includes standard forward-looking statement risks, such as clinical trial failures, regulatory delays, and partnership challenges.

01-04-2026

Cal-Maine Foods, Inc. (NASDAQ: CALM) announced the appointment of Dudley D. Wooley to its Board of Directors effective April 1, 2026, succeeding Jim Poole who recently passed away. Wooley, CEO of Ross & Yerger Insurance, Inc., brings over three decades of experience in risk management, business strategy, governance, and capital allocation, aligning with the company's long-term growth strategy toward diversified earnings. Board Chair Dolph Baker highlighted Wooley's value in navigating market dynamics and enhancing earnings visibility.

• ·Wooley holds MBA from Millsaps College, BS in Mathematics from Vanderbilt University, and certifications: CPCU, CRM, CIC, AAI.
• ·Serves as Trustee of Jones Family Trusts overseeing assets for ~170 beneficiaries.
• ·Recent risks noted: HPAI outbreak impacting flocks in March 2026; Echo Lake Foods acquisition completed June 2, 2025; ceased 'controlled company' status April 14, 2025.

01-04-2026

Bruker Corporation (Nasdaq: BRKR) announced the appointment of Thierry L. Bernard to its Board of Directors, effective April 1, 2026. Mr. Bernard, current CEO of QIAGEN N.V., brings decades of experience in life-science tools, diagnostics, and prior roles at bioMérieux SA. Chairman Frank H. Laukien highlighted Bernard's strategic track record to support Bruker's growth in post-genomic life sciences and diagnostics.

• ·Mr. Bernard joined QIAGEN in 2015 to lead molecular diagnostics and was named CEO in 2019; he plans to step down upon successor appointment.
• ·15 years at bioMérieux SA in roles including Corporate Vice President for Global Commercial Operations, Investor Relations, and Greater China Region.
• ·Named Chair of AdvaMedDx board in 2023 and joined Neogen Corporation board in 2024.
• ·Education: Sciences Po Paris, London School of Economics, College of Europe, Harvard Business School, Centro de Comercio Exterior de Barcelona.

01-04-2026

Elauwit Connection, Inc. (Nasdaq: ELWT) announced the appointment of James Di Bartolo as Chief Financial Officer effective April 2, 2026, replacing departing CFO Sean Arnette, who helped prepare the company for its IPO and initial public quarters. Executive Chairman Dan McDonough expressed excitement about Di Bartolo's financial acumen, capital markets experience from Goldman Sachs, Barclays, and others, to support growth in multifamily housing. No financial metrics or performance changes were disclosed.

• ·James Di Bartolo's prior roles: VP Structured Investing at Goldman Sachs (Oct 2024-Mar 2026), VP Strategic Transactions at Barclays (Jun 2021-Oct 2024)
• ·Company's 10-K for year ended Dec 31, 2025 filed Mar 31, 2026

01-04-2026

Whirlpool Corporation reported the termination of James Peters' employment on March 30, 2026, after he stepped down from his roles as Executive Vice President, Chief Financial and Administrative Officer, and President, Whirlpool Asia, effective January 1, 2026, as part of ongoing talent planning. Under the Waiver and Release Agreement, Peters will receive $3,046,500 in severance payments in two installments, eligibility for a prorated 2026 annual incentive award, and vesting of 20,000 restricted stock units contingent on compliance with waivers, restrictive covenants, and cooperation obligations.

• ·First severance installment payable within 30 days of March 30, 2026; second in March 2027.
• ·Prorated annual incentive under 2026 Executive Performance Excellence Plan determined in February 2027 based on target percentage and company performance.
• ·Restrictive covenants in effect for two years post-termination; ongoing cooperation covenant.

01-04-2026

On March 31, 2026, Greg Campbell resigned from the Board of Directors of Newton Golf Company, Inc. (NWTG), effective immediately, with no disagreement on the company's operations, policies, or practices. The filing was signed by Akinobu Yorihiro, Interim Chief Executive Officer and Chief Technology Officer. No other changes or compensatory arrangements were disclosed.

• ·Company is an emerging growth company.
• ·Common stock trades as NWTG on Nasdaq Stock Market LLC, par value $0.01 per share.
• ·Principal executive offices: 551 Calle San Pablo, Camarillo, CA 93012.

01-04-2026

On March 26, 2026, Bunge Global SA's Board of Directors approved the Executive Integration Incentive Program, a one-time performance-based restricted stock unit (PBRSU) plan for senior officers including the CEO, tied to cumulative run-rate cost synergy targets from the Viterra Limited acquisition integration over the 2026-2028 performance period. Key grants include 63,281 PBRSUs to CEO Gregory Heckman, 19,501 to COO Julio Garros, 12,099 to CFO John Neppl, 7,959 to EVP Christos Dimopoulos, and 3,900 to Chief Legal Officer Joseph Podwika. PBRSUs vest upon performance certification and continued employment through settlement.

• ·Performance period: January 1, 2026 to December 31, 2028, based on cumulative run-rate cost synergy targets.
• ·Vesting subject to Compensation Committee certification, continued employment, and for CEO/CFO, compliance with shareholder-approved Executive Management Team compensation cap.

01-04-2026

On March 31, 2026, Design Therapeutics, Inc. appointed David Shapiro, M.D. as a Class III director, effective immediately, with a term ending at the 2027 annual meeting of stockholders. Dr. Shapiro was also appointed to the Nominating and Corporate Governance Committee. Compensation includes annual cash retainers of $40,000 for Board service and $5,000 for Committee service, plus an initial option grant for 60,000 shares vesting over three years and a prorated grant for 7,500 shares vesting over one year.

• ·Initial option grant vests monthly over a three-year period.
• ·Prorated annual option grant vests monthly over a one-year period.
• ·Company entered into standard indemnification agreement with Dr. Shapiro.

01-04-2026

EPAM Systems, Inc.'s Board of Directors approved a grant of restricted stock units (RSUs) valued at $3,000,000 to Viktar Dvorkin, Senior Vice President and Global Head of Advanced Engineering, Cloud & Enterprise Platforms, effective March 31, 2026, under the 2025 Long Term Incentive Plan to provide retention incentives. The RSUs vest in equal one-third portions on the first, second, and third anniversaries of the grant date, subject to continuous employment, with acceleration provisions for death, disability, qualified retirement, or certain terminations.

• ·RSUs subject to forfeiture if employment terminates without qualifying events (death, disability, qualified retirement, or qualifying termination under Executive Severance Plan).
• ·RSU Agreement filed as Exhibit 10.1.

01-04-2026

Commercial Vehicle Group (CVGI) announced that Chief Financial Officer Andy Cheung will resign effective April 15, 2026, to become CFO of a mid-cap publicly traded company. Angie O’Leary, current Corporate Controller and Chief Accounting Officer, has been promoted to Interim CFO while retaining her existing roles. The company reaffirmed its full-year 2026 outlook from its Q4 2025 earnings release on March 10, 2026, and stated it does not intend to initiate a search for a permanent CFO replacement at this time.

• ·Angie O’Leary joined CVG as Senior Vice President, Corporate Controller and Chief Accounting Officer in December 2020; previously held roles at Vertiv Holdings Co. from May 2017 to December 2020, including Interim Corporate Controller, and at Deloitte & Touche LLP from January 2004 to May 2017, culminating as Senior Manager – Audit.
• ·Angie O’Leary holds a Bachelor of Science in Business Administration and Master of Accounting from The Ohio State University (2003) and is a Certified Public Accountant since 2005.
• ·Investor contacts: Michelle.Hards@cvgrp.com; Ross Collins or Nathan Skown at Alpha IR Group (15004906036.2).

01-04-2026

Natera, Inc.'s Board of Directors increased from ten to eleven members and appointed Eric Rubin as a Class I director effective March 26, 2026, based on the recommendation of the Nominating, Corporate Governance and Compliance Committee. Dr. Rubin was determined to be independent under Nasdaq standards, appointed to the same committee, and will receive cash and equity compensation consistent with other non-employee directors, with no family relationships or material interests disclosed.

• ·Dr. Rubin’s initial term as Class I director expires at the 2028 annual meeting of stockholders.
• ·Initial equity award to Dr. Rubin vests as to one-third on each of March 26, 2027, 2028, and 2029.
• ·Company entered into an Indemnification Agreement with Dr. Rubin.

01-04-2026

Nexscient, Inc. (NXNT) completed the acquisition of Flipside AI for $6.20 million, consisting of $600,000 cash, $450,000 convertible note, and 6,846,000 shares of restricted common stock, enhancing its Physical AI data engineering capabilities. Anthony S. De Luna, Flipside AI's founder and CEO, was appointed as Nexscient's Chief Technology Officer and Board Director. The deal positions Nexscient to capitalize on the AI robotics market projected to grow from $16.1 billion in 2024 to $124.8 billion by 2030.

• ·Acquisition includes satisfaction of all customary closing conditions, multi-step reorganization, regulatory filings, and government clearances.
• ·Flipside AI founded in 2010, pivoted to AI data engineering in 2018; serves automotive OEMs, Tier-1 suppliers, autonomous vehicle programs, robotics developers, and satellite intelligence platforms.
• ·Anthony S. De Luna has over three decades of experience, including XML at Innodata Inc. (1990s), EPUB at Barnes & Noble (2000s), and Physical AI from 2018.

01-04-2026

Booking Holdings Inc. (BKNG) appointed Kurt Sievers, retired CEO of NXP Semiconductors, to its Board of Directors effective April 1, 2026, bringing experience in technology, mobility, and global markets from roles including leading NXP's acquisition of Marvell’s Wi-Fi Connectivity Business Unit and the 2015 merger with Freescale Semiconductor. Concurrently, Director Lynn Radakovich announced her retirement from the Board effective at the company's Annual Meeting in June 2026 after a decade of service providing leadership in global business, technology, sales, and marketing.

• ·Kurt Sievers served as President and CEO of NXP Semiconductors from 2020 until retirement in 2025; previously President from 2018 and joined Executive Management Team in 2009.
• ·Kurt Sievers currently serves on boards of Capgemini SE (Strategy & CSR and Compensation Committees) and supervisory board of Daimler Truck Holding AG.
• ·Filing date: April 01, 2026; Items 5.02, 7.01, 9.01.

01-04-2026

On March 31, 2026, the Board of Directors of Alkami Technology, Inc. approved the appointment of Jeffrey Fox and Judson Linville as new directors, effective immediately following the 2026 Annual Meeting of Stockholders. The Board size will increase from 9 to 11 directors, with Class I and Class III each expanding from 3 to 4 members. Both new directors bring extensive experience in financial services and technology, with no reportable related-party transactions.

• ·Mr. Linville's term as Class III director expires at 2027 annual meeting.
• ·Mr. Fox's term as Class I director expires at 2028 annual meeting.
• ·New directors will receive compensation per the Company's non-employee director program described in the March 31, 2025 proxy statement.
• ·No transactions or relationships reportable under Item 404(a) of Regulation S-K.
• ·Board to determine committee assignments post-appointment.

01-04-2026

NovaBay Pharmaceuticals, Inc. amended its Second Amended and Restated Certificate of Incorporation to change its name to Stablecoin Development Corporation, effective at 4:15 p.m. Eastern Time on April 2, 2026. The Board of Directors adopted the amendment via resolutions under Sections 141 and 242 of the Delaware General Corporation Law, without a stockholder vote. The certificate was signed by CEO Michael Kazley on March 31, 2026.

• ·Corporation originally incorporated on April 19, 2010.
• ·Amendment amends Article I of the Second Amended and Restated Certificate of Incorporation.

01-04-2026

HubSpot, Inc. (NYSE: HUBS) announced the appointment of Mike Berry, Chief Financial Officer of MongoDB, to its Board of Directors, effective April 1, 2026. Berry brings more than 30 years of experience in finance, operations, and general management from leading technology companies including NetApp and McAfee. CEO Yamini Rangan praised Berry's financial expertise, governance track record, and understanding of AI as invaluable for scaling HubSpot's agentic customer platform globally.

• ·Mike Berry holds a bachelor's degree in finance from Augsburg College and an MBA from the University of St. Thomas.
• ·Berry serves on the boards of directors of Rapid7 and Calix.
• ·Appointment announced via Exhibit 99.1 press release on April 1, 2026.

01-04-2026

Four Corners Property Trust (NYSE: FCPT) appointed Michael Friedland to its Board of Directors, effective April 1, 2026. Friedland brings over 30 years of experience in real estate finance, corporate credit underwriting, and banking, including over 20 years of executive leadership, most recently as Vice Chair of Global Corporate Banking at JPMorgan Chase Bank, N.A. until March 2026. CEO Bill Lenehan praised Friedland's expertise in supporting FCPT's balance sheet.

• ·Friedland started career at Bankers Trust Corporation on Real Estate Industries Team.
• ·Joined JPM in 1994 as Managing Director in Syndicated and Leveraged Finance Group.
• ·Head of Real Estate Special Credits and Workout Group from 2010 to 2012.
• ·Group Manager of Global Corporate Banking-Real Estate in 2012; promoted to Vice Chair in 2022.
• ·Holds M.B.A. in Finance from New York University and B.A. cum laude from Tufts University.

01-04-2026

Akebia Therapeutics, Inc. (Nasdaq: AKBA) appointed biopharmaceutical leader Philip Vickers, Ph.D., President and CEO of Solu Therapeutics, to its Board of Directors effective April 1, 2026, citing his extensive experience in drug development and business strategy. Concurrently, Steven C. Gilman, Ph.D. retired from the Board effective the same date, after serving since the 2018 merger with Keryx. The changes occur as Akebia advances programs in kidney and rare diseases.

• ·Dr. Vickers has over three decades of biopharmaceutical experience, including CEO roles at Faze Medicines and Northern Biologics, and Executive VP and Global Head of R&D at Shire.
• ·Dr. Gilman previously served on Keryx Board since March 2016.
• ·Dr. Vickers holds a Ph.D. from the University of Toronto and has co-authored ~60 peer-reviewed publications and numerous patents.

01-04-2026

On March 31, 2026, the Compensation Committee of Tron Inc. approved an increase in the annual salary of President Taft Flittner, a named executive officer, from $100,000 to $120,000, effective immediately. The 8-K filing was signed by CEO Richard Miller on April 1, 2026. No other changes in officers or directors were reported.

• ·Tron Inc. is an emerging growth company.
• ·Common Stock trades under symbol TRON on The Nasdaq Capital Market.

01-04-2026

Associated Banc-Corp completed its merger with American National Corporation and its bank subsidiary, American National Bank, enhancing organic growth potential in markets like Omaha and the Twin Cities. The acquisition builds on Associated's strong 2025 performance, including relationship loan and deposit growth, record customer growth, solid credit performance, and the strongest annual net income in company history. Wende Kotouc, former Executive Co-Chairperson and Co-CEO of American National Bank, was appointed to Associated's Board of Directors.

• ·American National systems, branches, and customers expected to convert to Associated in Q3 2026.
• ·Associated operates over 200 banking locations in Wisconsin, Illinois, Iowa, Minnesota, Missouri, and Nebraska, with loan production offices in Indiana, Kansas, Michigan, New York, Ohio, and Texas.

01-04-2026

Axe Compute Inc. (NASDAQ: AGPU) announced approximately $12 million in executed agreement value across 20+ enterprise customers in the last 30 days, providing an estimated $835 thousand in monthly income upon deployment entering Q2 2026, representing about $7.5 million in estimated 2026 income based on the current run rate. The agreements cover 30+ active deployments across GPU architectures including RTX 5090, H100, H200, and B200, structured for predictable recurring income with monthly payments in advance. CEO Chris Miglino emphasized the production quality of these enterprise contracts amid a market projecting $2.5 trillion in worldwide AI spending in 2026.

• ·All enterprise agreements structured with monthly payment in advance against reserved capacity commitments to eliminate receivables risk.
• ·Operates across Tier 3 and Tier 4 data center GPU providers in 200+ global locations for 24-48 hour deployments.

01-04-2026

cbdMD, Inc. held its 2026 Annual Meeting on March 30, 2026, with 54.6% shareholder turnout (5,732,044 of 10,495,561 shares), approving all seven proposals including director elections, auditor ratification, a potential reverse stock split (1:2 to 1:10), and share issuances under Series B/C preferred stock and ELOC agreements that could cause significant dilution. The 2025 Equity Compensation Plan was approved (1,854,961 For vs. 1,052,954 Against and 2,807,382 broker non-votes), reserving 891,316 shares initially with an evergreen provision adding up to 300,000 shares annually. CEO T. Ronan Kennedy received 445,000 restricted shares upon approval, amid substantial opposition on dilutive proposals.

• ·Proposal 1 director elections showed significant 'Withheld' votes (e.g., Bakari Sellers: 700,025 Withheld vs. 2,224,637 For; T. Ronan Kennedy: 65,400 Withheld vs. 2,859,262 For)
• ·Proposal 3 reverse stock split approval: 3,420,668 For vs. 2,215,228 Against
• ·Proposal 4 Series B issuance: 1,872,202 For vs. 1,035,956 Against
• ·Proposal 5 Series C issuance: 1,873,290 For vs. 1,035,798 Against
• ·Proposal 6 ELOC issuance: 1,868,900 For vs. 1,039,934 Against
• ·Proposal 2 auditor ratification: 4,098,687 For vs. 43,614 Against (1,589,743 Abstain)

01-04-2026

On March 26, 2026, the Compensation Committee of Liberty Global Ltd. approved the 2026 Performance Awards for executive officers, including a $13.0 million target for CEO Michael T. Fries and $2.75 million to $5.0 million targets for the other four anticipated 2026 NEOs, based on budgeted revenue, adjusted EBITDA metrics, and strategic goals with payouts ranging from 0% to 150% (up to 180% individually). The Committee also approved the 2026 Long-Term Incentive Program for approximately 480 participants, with target equity values of $16,000,000 for the CEO and $4.25 million to $6.25 million for other NEOs, allocated as 50% PSUs tied to absolute share price performance over 2026-2028, 10% LGIP based on Liberty Growth portfolio valuation growth, and 40% time-vesting RSUs. No performance outcomes are reported, as these are forward-looking incentive structures.

• ·PSUs cover fiscal years 2026-2028 with cliff vesting on February 15, 2029, based solely on absolute share price performance adjusted for corporate events.
• ·LGIP performance measured against Liberty Growth portfolio valuation as of December 31, 2025, settled in cash or shares at Committee's election.
• ·RSUs vest in equal installments on May 1 of 2027, 2028, and 2029.
• ·Executives may elect up to 100% of Performance Awards in Class A/C ordinary shares (CEO any Class A/B/C), with 12.5% illiquidity premium in RSUs vesting March 1 following issuance if shares held.
• ·Aggregate employee payouts capped at budgeted bonus amount.

01-04-2026

Avantor, Inc. (NYSE: AVTR) announced that Executive Vice President and CFO R. Brent Jones will depart on or before June 24, 2026, with Senior Vice President and CAO Steve Eck appointed as interim CFO to ensure a smooth transition. The company has initiated a search for a permanent CFO successor. Avantor reaffirmed its fiscal 2026 financial guidance originally provided on February 11, 2026.

• ·Steve Eck has served as CAO since 2019, overseeing financial reporting and internal controls.
• ·Investor Relations contact: Chris.Fidyk@avantorsciences.com
• ·Global Media contact: Eric.VanZanten@avantorsciences.com, 610-529-6219

01-04-2026

ContextLogic Holdings Inc. (OTCQB: LOGC) appointed Paul S. Levy as an independent director and member of the Audit Committee on April 1, 2026; Mr. Levy, founder of JLL Partners with 40 years of experience, will waive director compensation like directors from Abrams Capital and BC Partners. Chairman Raja Bobbili praised Levy's expertise in building enduring businesses and noted his status as a significant shareholder. The appointment aligns with ContextLogic's strategy as a business ownership platform for high-quality, long-duration businesses.

• ·Mr. Levy previously served as Chairman of Builders FirstSource, Inc. and CEO of Yves Saint Laurent, Inc.
• ·Mr. Levy holds a B.A. from Lehigh University and a J.D. from the University of Pennsylvania Law School.

01-04-2026

Yum! Brands, Inc. appointed Kathleen K. Oberg as a director, effective April 1, 2026, following a Board decision on March 26, 2026; she will stand for election by shareholders at the next Annual Meeting. Ms. Oberg will receive a one-time stock grant with a fair market value of $25,000 and a prorated portion of her annual stock retainer, consistent with standard non-employee director compensation. As of the filing, she has not been appointed to any Board committee, and there are no arrangements influencing her selection.

• ·Appointment announced in Form 8-K filed April 1, 2026.
• ·Ms. Oberg has not been appointed to a committee of the Board as of the filing date.
• ·No arrangement or understanding with any other person pursuant to which Ms. Oberg was selected as a director.

01-04-2026

Clover Health Investments, Corp. (Nasdaq: CLOV) announced the departure of Chief Financial Officer Peter Kuipers effective March 30, 2026, with no disagreements on operations, policies, or practices, and his continued advisory role through April 24, 2026. The Board appointed Clay Thornton, current CFO of Clover’s insurance plan, as Interim Chief Financial Officer effective immediately. The company reiterated its full fiscal year 2026 financial guidance originally issued on February 26, 2026, emphasizing prior achievements in profitability and growth.

• ·Peter Kuipers' departure reflects focus on execution, operational efficiency, and disciplined capital allocation during his tenure.
• ·Clay Thornton's prior experience includes financial and strategic roles at Humana in Medicare Advantage, plus venture capital and private equity.
• ·Forward-looking statements reference potential improvements in revenues, operating expenses, Consolidated Gross profit, Adjusted SG&A, and Insurance members for FY2026.

01-04-2026

Femasys Inc. (NASDAQ: FEMY) appointed John Canning as Chief Operating Officer effective April 1, 2026, to enhance operational execution and support commercial growth of its fertility and permanent birth control portfolio, including FemBloc® and FemaSeed®. Canning brings over 25 years of medical device experience from roles at Terumo Aortic, Bolton Medical, and Medtronic Vascular. The company granted him an inducement stock option for 150,000 shares, vesting 25% annually over four years.

• ·FemBloc® received full regulatory approval in Europe (June 2025), UK (August 2025), and New Zealand (September 2025).
• ·Stock option exercise price equals Nasdaq closing price on grant date; approved under Nasdaq Listing Rule 5635(c)(4).

01-04-2026

Ascent Industries Co. appointed Carmen J. Giannantonio and Jeremy F. Rohen to its Board of Directors effective April 1, 2026, reflecting its transformation into a pure-play specialty chemicals company and commitment to strategic alignment. The appointees bring over 40 years of combined experience in specialty chemicals, M&A (including transactions exceeding $200 billion), distribution, and portfolio transformation. Current Board member and Audit Committee Chair John P. Schauerman will not stand for reelection after serving since June 2020.

• ·Carmen J. Giannantonio holds MBA from Drexel University, MS in Taxation from Widener University, BS in Accounting from Villanova University
• ·Jeremy F. Rohen holds MS in Taxation and BS in Finance from The George Washington University School of Business
• ·Investor Relations contact: 1-630-844-9181, investorrelations@ascentco.com

01-04-2026

Effective April 1, 2026, Keiji Okuno resigned as a member of Aircastle Limited's Board of Directors, where he had served since September 2022 and was a member of the Audit and Investment Committees. Yasuhiko Hashimoto, Managing Executive Officer at Mizuho Leasing Company Limited, was simultaneously appointed to the Board and to the Audit and Compensation Committees, nominated by Mizuho Leasing per the Company's Bye-Laws. Mr. Hashimoto will receive no compensation from Aircastle for his directorship.

• ·Keiji Okuno served on Aircastle's Audit and Investment Committees.
• ·Yasuhiko Hashimoto joined Mizuho Leasing in June 2021; previously over 30 years at Mizuho Bank in roles including Head of Global Products Unit and Deputy Head of EMEA.
• ·Yasuhiko Hashimoto holds MBA from NYU Stern School of Business and Bachelor of Law from University of Osaka.

01-04-2026

Hope Bancorp, Inc. and its subsidiary Bank of Hope promoted Peter J. Koh to President & Chief Operating Officer of the Bank, effective April 1, 2026, following Board approval on March 26, 2026; previously, he served as Senior Executive Vice President and COO. Kevin S. Kim will continue as Chairman and CEO of both the Company and Bank, and as President of the Company. The promotion includes an increase in Mr. Koh's base salary to $600,000, with short-term incentive target at 80% of salary and long-term incentive target at 80% of base salary.

• ·No family relationships between Mr. Koh and any current directors or executive officers of the Company or Bank, except relation to former director Steven S. Koh who retired December 31, 2025.
• ·No arrangements or understandings pursuant to which Mr. Koh was selected.
• ·Mr. Koh has no direct or indirect material interest in any transaction required to be disclosed under Item 404(a) of Regulation S-K.
• ·Mr. Koh's identification and business experience described in proxy statement on Schedule 14A filed April 11, 2025.

01-04-2026

On March 30, 2026, John Westerfield, a member of the Board of Directors of BrightSpire Capital, Inc., informed the Board that he will retire and not stand for re-election at the Company's 2026 Annual Meeting on May 13, 2026, to focus on other professional endeavors. His retirement is not due to any disagreement with the Company's operations, policies, or practices. The filing was made on April 1, 2026.

01-04-2026

Hovnanian Enterprises, Inc. held its 2026 Annual Meeting of Stockholders on March 31, 2026, where all eight directors were elected with strong majorities (For votes ranging from 9,354,765 to 10,562,136), Deloitte & Touche LLP was ratified as independent auditor (11,603,036 For vs. 41,110 Against), the Fourth Amended and Restated 2020 Stock Incentive Plan was approved (9,919,750 For vs. 869,569 Against, increasing share reserve by 100,000 shares), and executive compensation received advisory approval (9,928,102 For vs. 822,158 Against). While all proposals passed comfortably, opposition was notable for directors like V. Pagano Jr. (1,438,486 Against) and E. Kangas (1,157,515 Against). No declines or failures occurred.

• ·Director election votes - A. Hovnanian: 9,853,568 For, 939,895 Against; R. Coutts: 10,128,727 For, 629,903 Against; M. Hernandez-Kakol: 10,392,118 For, 399,994 Against; E. Kangas: 9,635,760 For, 1,157,515 Against; J. Marengi: 9,626,038 For, 1,167,213 Against; V. Pagano Jr.: 9,354,765 For, 1,438,486 Against; R. Sellers: 9,966,267 For, 825,940 Against; J. Sorsby: 10,562,136 For, 231,175 Against
• ·Stock Incentive Plan approval: 9,919,750 For, 869,569 Against, 5,230 Abstentions
• ·Advisory vote on executive compensation: 9,928,102 For, 822,158 Against, 44,289 Abstentions